Cibus, Inc. (CBUS) stock: key figures, P/E, revenue and dividend
Materials · United States · ISIN US17166A1016
Cibus, Inc. financials
| Fiscal year | 2025 |
|---|---|
| Revenue | 3.64 m USD |
| Operating income | -97.53 m USD |
| EBIT | -132.17 m USD |
| Net income | -127.09 m USD |
| Diluted EPS – continuing operations | -2.78 USD |
Full history since 2014, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Cibus, Inc.
Cibus, Inc. is an agricultural biotechnology company that develops and licenses gene-edited plant traits. The company's products enable farmers to achieve higher yields and reduce the use of chemicals, such as fungicides, insecticides and fertilizers, and offer sustainable ingredients. it has patented core technology platform, RTDS, a scalable, standardized, end-to-end, semi-automated and high-throughput gene-editing system marketed under the Trait Machine brand name. The company was formerly known as Calyxt, Inc. and changed its name to Cibus, Inc. in June 2023. Cibus, Inc. was incorporated in 2010 and is headquartered in San Diego, California.
More stocks
- Loop Telecommunication International Inc (3025.TW)
- Hanjin Heavy Ind & Const Holdings Co Ltd (003480.KS)
- First Resource Bank (FRSB)
- SK Securities ACPC No.7 Special Purpose Acquisition Co. Ltd. (408920.KQ)
- JELD-WEN Holding, Inc. (JELD)
- Kuen Ling Refrigerating Machinery Co Ltd (4527.TWO)
- Tamawood Ltd (TWD.AX)
- HLS Therapeutics Inc (HLS.TO)
- InsCorp Inc (IBTN)
- Genic Co. Ltd (123330.KQ)
- Lee Ku Ind (025820.KS)
- Empress Royalty Corp (EMPR.V)
Not investment advice. All data without warranty, price as of 29.10.2026. Details in the risk notice.